Subtype
Soft Tissue Sarcoma
CI-CAN-00001533Explore in graph →
338 active trials9 approved drugs37 evidence items
- NCIt
- C9306
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001533Explore in graph →
Clinical trials
1,383 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (195)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04757337 | Comparison of Oral Cyclophosphamide vs Doxorubicin in ≥65 Years Old Advanced or Metastatic Soft Tissue Sarcoma Patients(GERICO14) | unknown | Phase 3 | 214 | UNICANCEROTHER | 1 | Mar 25, 2025 | clinicaltrials |
| NCT06593899 | The Total Neoadjuvant Therapy for Soft Tissue Sarcoma of the Extremities | unknown | Phase 2 | 51 | Fujian Medical University Union HospitalOTHER | 1 | Sep 19, 2024 | clinicaltrials |
| NCT03375437 | RNASARC - Molecular Screening Program of Soft Tissue Sarcomas With Complex Genomic Profile to Detect NTRK1/2/3, ROS1 or ALK Gene Fusions.(RNASARC) | unknown | N/A | 376 | Centre Leon BerardOTHER | 1 | Aug 26, 2024 | clinicaltrials |
| NCT05607602 | Are Uterine Fibroids Pro-thrombotic? | unknown | — | 105 | King's College Hospital NHS TrustOTHER | 1 | Jun 11, 2024 | clinicaltrials |
| NCT02910895 | A Platform of Patient Derived Xenografts (PDX) and 2D/3D Cell Cultures of Soft Tissue Sarcomas (STS)(SarcomaPDX) | unknown | N/A | 40 | The Netherlands Cancer InstituteOTHER | 1 | Jun 7, 2024 | clinicaltrials |
| NCT05955105 | A Study of ILB2109 and Toripalimab in Patients With Advanced Solid Malignancies | unknown | Phase 1 / Phase 2 | 200 | Innolake BiopharmINDUSTRY | 1 | May 21, 2024 | clinicaltrials |
| NCT04480502 | ENVASARC: Envafolimab And Envafolimab With Ipilimumab In Patients With Undifferentiated Pleomorphic Sarcoma Or Myxofibrosarcoma(ENVASARC) | unknown | Phase 2 | 207 | Tracon Pharmaceuticals Inc.INDUSTRY | 2 | May 17, 2024 | clinicaltrials |
| NCT05081141 | HHV8 and Solid Organ Transplantation | unknown | — | 250 | Fondazione IRCCS Ca' Granda, Ospedale Maggiore PoliclinicoOTHER | 1 | May 7, 2024 | clinicaltrials |
| NCT03993106 | A Study of sEphB4-HSA in Kaposi Sarcoma | unknown | Phase 2 | 65 | Vasgene Therapeutics, IncINDUSTRY | 1 | May 2, 2024 | clinicaltrials |
| NCT04032964 | Dose Finding Study of L19TNF and Doxorubicin in Patients With STS(DOXO75) | unknown | Phase 1 | 2 | Philogen S.p.A.INDUSTRY | 1 | Apr 8, 2024 | clinicaltrials |
| NCT04650984 | A Study Comparing the Efficacy of L19TNF+Doxorubicin vs Doxorubicin Alone as First-line Therapy in Patients With Advanced or Metastatic Soft Tissue Sarcoma(FIBROSARC) | unknown | Phase 3 | 102 | Philogen S.p.A.INDUSTRY | 5 | Apr 8, 2024 | clinicaltrials |
| NCT05057195 | Wide Excision of Soft Tissue Sarcomas in Combination With Interstitial Radiation Therapy | unknown | N/A | 78 | Blokhin's Russian Cancer Research CenterOTHER | 1 | Apr 1, 2024 | clinicaltrials |
| NCT05189483 | Albumin-bound Paclitaxel Plus Camrelizumab for Advanced Soft Tissue Sarcoma. | unknown | Phase 2 | 40 | Henan Cancer HospitalOTHER_GOV | 1 | Feb 7, 2024 | clinicaltrials |
| NCT05718778 | Piamprilizumab (AK105) Combined With Radiotherapy for Neoadjuvant Treatment of Soft Tissue Sarcoma | unknown | N/A | 31 | Henan Cancer HospitalOTHER_GOV | 1 | Feb 7, 2024 | clinicaltrials |
| NCT06234670 | Risk Factors and A Prediction Model of Recurrence of Uterine Fibroids | unknown | — | 3,200 | Wenwen WangOTHER | 1 | Jan 31, 2024 | clinicaltrials |
| NCT03242382 | Trial of Palbociclib in Second Line of Advanced Sarcomas With CDK4 Overexpression.(PalboSarc) | unknown | Phase 2 | 40 | Grupo Espanol de Investigacion en SarcomasOTHER | 1 | Jan 23, 2024 | clinicaltrials |
| NCT04595994 | Selinexor Plus Gemcitabine in Selected Advanced Soft-tissue Sarcoma and Osteosarcoma(SeliSarc) | unknown | Phase 1 | 14 | Grupo Espanol de Investigacion en SarcomasOTHER | 1 | Jan 23, 2024 | clinicaltrials |
| NCT04589754 | Adriamycin and Ifosfamide Combined With Sintilimab | unknown | Phase 2 | 176 | Sun Yat-sen UniversityOTHER | 1 | Jan 2, 2024 | clinicaltrials |
| NCT04927260 | French Long Term Registry With Longitudinal Follow up of PDGFRA D842V-GIST Patients(AVIATOR2020) | unknown | — | 25 | Centre Leon BerardOTHER | 1 | Dec 26, 2023 | clinicaltrials |
| NCT06165718 | Study for the Clinical Roadmap and Prognosis of Pulmonary Artery Sarcoma. | unknown | — | 120 | China-Japan Friendship HospitalOTHER | 1 | Dec 15, 2023 | clinicaltrials |
| NCT06171282 | A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Advanced Bone and Soft Tissue Tumors | unknown | Early Phase 1 | 9 | Shanghai Yunying Medical TechnologyINDUSTRY | 1 | Dec 14, 2023 | clinicaltrials |
| NCT03134742 | Radiation Effects on Bone | unknown | — | 50 | State University of New York - Upstate Medical UniversityOTHER | 1 | Nov 21, 2023 | clinicaltrials |
| NCT03600649 | Clinical Trial of SP-2577 (Seclidemstat) in Patients With Relapsed or Refractory Ewing or Ewing-related Sarcomas | unknown | Phase 1 | 50 | Salarius Pharmaceuticals, LLCINDUSTRY | 1 | Nov 21, 2023 | clinicaltrials |
| NCT06117878 | Safety and Efficacy of NK510 to Treat Osteosarcoma and Soft Tissue Sarcoma | unknown | Early Phase 1 | 12 | Base Therapeutics (Shanghai) Co., Ltd.INDUSTRY | 1 | Nov 7, 2023 | clinicaltrials |
| NCT06114173 | Efficacy and Safety Study of Cardunilizumab in Soft Tissue Sarcoma | unknown | Early Phase 1 | 15 | Xiangya Hospital of Central South UniversityOTHER | 1 | Nov 2, 2023 | clinicaltrials |
| NCT06110650 | A Study of Surufatinib in the Treatment of Advanced Soft Tissue Sarcoma | unknown | N/A | 29 | Fudan UniversityOTHER | 0 | Oct 31, 2023 | clinicaltrials |
| NCT05684874 | Multiparametric Quantitative MRI and Response to Neoadjuvant Radiotherapy for Soft-tissue Sarcoma(SarQuantIRM) | unknown | N/A | 25 | Centre Leon BerardOTHER | 1 | Oct 30, 2023 | clinicaltrials |
| NCT03792867 | Radical Resection and HIPEC for Recurrent Retroperitoneal Sarcoma | unknown | N/A | 5 | National Cancer Centre, SingaporeOTHER | 1 | Oct 11, 2023 | clinicaltrials |
| NCT05329792 | L19IL2/L19TNF in Skin Cancer Patients(IntriNSiC) | unknown | Phase 2 | 70 | Philogen S.p.A.INDUSTRY | 3 | Oct 6, 2023 | clinicaltrials |
| NCT05448820 | YH001 Plus Envafolimab With or Without Doxorubicin in Patients With Advanced or Metastatic Sarcoma | unknown | Phase 1 / Phase 2 | 15 | Tracon Pharmaceuticals Inc.INDUSTRY | 1 | Sep 21, 2023 | clinicaltrials |
| NCT02495311 | The Association Between Adenomyosis/Uterine Myoma and Lower Urinary Tract Symptoms | unknown | — | 150 | Far Eastern Memorial HospitalOTHER | 1 | Sep 15, 2023 | clinicaltrials |
| NCT04311073 | Prophylactic Tranexamic Acid During Minimally Invasive Myomectomies | unknown | Phase 3 | 50 | Eastern Virginia Medical SchoolOTHER | 1 | Sep 11, 2023 | clinicaltrials |
| NCT06020924 | The Effects of Uterine Fibroids on Pregnancy in Women | unknown | — | 1,658 | Wenwen WangOTHER | 1 | Sep 1, 2023 | clinicaltrials |
| NCT06009562 | Management of Symptomatic Uterine Fibroids in Pregnancy by Laparotomic Myomectomy: a Prospective Cohort Study(LPTM-UFs-P) | unknown | — | 28 | University of PalermoOTHER | 1 | Aug 24, 2023 | clinicaltrials |
| NCT05266196 | A Rollover Protocol to Allow for Continued Access to the LSD1 Inhibitor Seclidemstat (SP-2577) | unknown | Phase 1 / Phase 2 | 10 | Salarius Pharmaceuticals, LLCINDUSTRY | 1 | Aug 1, 2023 | clinicaltrials |
| NCT05078307 | Evaluation of a Hysteroscopic Method With Vaporization in the Hysteroscopic Treatment of Submucosal Uterine Fibroids(VAPOHYSTERO) | unknown | N/A | 54 | Assistance Publique Hopitaux De MarseilleOTHER | 1 | Jul 27, 2023 | clinicaltrials |
| NCT05963035 | Clinical Application of 18F-PFPN PET Imaging in Diagnosis and Staging of Clear Cell Sarcoma of Soft Tissue | unknown | N/A | 10 | Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyOTHER | 1 | Jul 27, 2023 | clinicaltrials |
| NCT05881967 | Molecular Mechanism Study of Uterine Sarcoma | unknown | — | 300 | Shixuan WangOTHER | 1 | May 31, 2023 | clinicaltrials |
| NCT05442333 | Adjuvant Versus Neo-adjuvant Radiotherapy in Patients With Resectable Soft Tissue Sarcoma in Extremities : Wound Complications | unknown | N/A | 20 | Ain Shams UniversityOTHER | 1 | May 17, 2023 | clinicaltrials |
| NCT05851456 | A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Bone and Soft Tissue Tumors | unknown | Early Phase 1 | 20 | Shanghai Yunying Medical TechnologyINDUSTRY | 1 | May 9, 2023 | clinicaltrials |
| NCT04240262 | Microwave Ablation for Leiomyoma(MYOMIC2) | unknown | — | 200 | Karolinska InstitutetOTHER | 1 | May 1, 2023 | clinicaltrials |
| NCT04318964 | TAEST16001 in the Treatment of Soft Tissue Sarcoma | unknown | Phase 1 | 12 | Sun Yat-sen UniversityOTHER | 1 | Apr 12, 2023 | clinicaltrials |
| NCT05695690 | Role of US in Uterine Fibroids in Comparison With MRI Using FIGO Classification | unknown | — | 43 | Assiut UniversityOTHER | 0 | Apr 11, 2023 | clinicaltrials |
| NCT03985722 | Olaratumab Plus Trabectedin in Advanced Soft-tissue Sarcoma Patients Soft-tissue Sarcoma Patients(OLATRASTS) | unknown | Phase 1 | 28 | Grupo Espanol de Investigacion en SarcomasOTHER | 1 | Mar 27, 2023 | clinicaltrials |
| NCT04138381 | Selinexor as Single Agent and With Imatinib in Metastatic and/or Unresectable Gastrointestinal Stromal Tumors (SeliGIST)(SeliGIST) | unknown | Phase 1 / Phase 2 | 30 | Grupo Espanol de Investigacion en SarcomasOTHER | 1 | Mar 27, 2023 | clinicaltrials |
| NCT05131386 | Multicohort Trial of Trabectedin and Low-dose Radiation Therapy in Advanced/Metastatic Sarcomas(SYNERGIAS) | unknown | Phase 2 | 85 | Grupo Espanol de Investigacion en SarcomasOTHER | 1 | Mar 27, 2023 | clinicaltrials |
| NCT05778955 | Study on Dynamic CtDNA Analysis in Pediatric Soft Tissue Sarcoma | unknown | — | 40 | Sun Yat-sen UniversityOTHER | 1 | Mar 22, 2023 | clinicaltrials |
| NCT05620355 | Efficacy and Safety of BG2109 in Subjects With Heavy Menstrual Bleeding Associated With Uterine Fibroids. | unknown | Phase 3 | 312 | Bio Genuine (Shanghai) Biotech Co., Ltd.INDUSTRY | 1 | Mar 21, 2023 | clinicaltrials |
| NCT03475953 | A Phase I/II Study of Regorafenib Plus Avelumab in Solid Tumors(REGOMUNE) | unknown | Phase 1 / Phase 2 | 747 | Institut BergoniéOTHER | 1 | Mar 3, 2023 | clinicaltrials |
| NCT05747521 | Anrotinib Hydrochloride Combined With Adriamycin for Neoadjuvant Treatment of High-grade Soft Tissue Sarcoma | unknown | N/A | 85 | Henan Cancer HospitalOTHER_GOV | 1 | Feb 28, 2023 | clinicaltrials |
Data updated 22 days agoSource updated Mar 25, 2025source: clinicaltrials